PARK2 Microduplication: Clinical and Molecular Characterization of a Further Case and Review of the Literature

Orazio Palumbo, Pietro Palumbo, Maria P. Leone, Raffaella Stallone, Teresa Palladino, Marcella Vendemiale, Stefano Palladino, Francesco Papadia, Massimo Carella, Rira Fischetto

Research output: Contribution to journalArticle

Abstract

We report on a patient with psychomotor deficits, language delay, dyspraxia, skeletal anomalies, and facial dysmorphisms (hirsutism, right palpebral ptosis, a bulbous nasal tip with enlarged and anteverted nares, and a mild prominent antihelix stem). Using high-resolution SNP array analysis, we identified a 0.49-Mb microduplication in chromosome 6q26 inherited from the mother involving the PARK2 gene: arr[hg19] 6q26(162,672,821-163,163,143)×3 mat. To the best of our knowledge, this is the third patient to date described in whom a 6q26 microduplication encompassing only the PARK2 gene has been reported in medical literature. The PARK2 gene is a neurodevelopmental gene that was initially discovered as one of the causes of autosomal recessive juvenile Parkinson disease and subsequently reported to be linked to autism spectrum disorders and attention-deficit hyperactivity disorders. We provide an overview of the literature on PARK2 microduplications and further delineate the associated phenotype. Taken together, our findings confirm the involvement of this gene in neurodevelopmental disorders and are useful to strengthen the hypothesis that, although with variable expressivity and incomplete penetrance, the PARK2 microduplication is associated with a new emerging neurodevelopmental delay syndrome. However, clinical and molecular evaluations of more patients with the microduplication are needed for full delineation of this syndrome.

Original languageEnglish
JournalMolecular Syndromology
DOIs
Publication statusAccepted/In press - Sep 2 2016

Fingerprint

Genes
Language Development Disorders
Apraxias
Hirsutism
Penetrance
Parkinsonian Disorders
Eyelids
Attention Deficit Disorder with Hyperactivity
Nose
Single Nucleotide Polymorphism
Chromosomes
Mothers
Phenotype
Autism Spectrum Disorder
Neurodevelopmental Disorders

Keywords

  • <italic>PARK2</italic>
  • Neurodevelopmental disorders
  • SNP array analysis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

PARK2 Microduplication : Clinical and Molecular Characterization of a Further Case and Review of the Literature. / Palumbo, Orazio; Palumbo, Pietro; Leone, Maria P.; Stallone, Raffaella; Palladino, Teresa; Vendemiale, Marcella; Palladino, Stefano; Papadia, Francesco; Carella, Massimo; Fischetto, Rira.

In: Molecular Syndromology, 02.09.2016.

Research output: Contribution to journalArticle

Palumbo, Orazio ; Palumbo, Pietro ; Leone, Maria P. ; Stallone, Raffaella ; Palladino, Teresa ; Vendemiale, Marcella ; Palladino, Stefano ; Papadia, Francesco ; Carella, Massimo ; Fischetto, Rira. / PARK2 Microduplication : Clinical and Molecular Characterization of a Further Case and Review of the Literature. In: Molecular Syndromology. 2016.
@article{9a065a35e92a4cef881be5a3d54472cf,
title = "PARK2 Microduplication: Clinical and Molecular Characterization of a Further Case and Review of the Literature",
abstract = "We report on a patient with psychomotor deficits, language delay, dyspraxia, skeletal anomalies, and facial dysmorphisms (hirsutism, right palpebral ptosis, a bulbous nasal tip with enlarged and anteverted nares, and a mild prominent antihelix stem). Using high-resolution SNP array analysis, we identified a 0.49-Mb microduplication in chromosome 6q26 inherited from the mother involving the PARK2 gene: arr[hg19] 6q26(162,672,821-163,163,143)×3 mat. To the best of our knowledge, this is the third patient to date described in whom a 6q26 microduplication encompassing only the PARK2 gene has been reported in medical literature. The PARK2 gene is a neurodevelopmental gene that was initially discovered as one of the causes of autosomal recessive juvenile Parkinson disease and subsequently reported to be linked to autism spectrum disorders and attention-deficit hyperactivity disorders. We provide an overview of the literature on PARK2 microduplications and further delineate the associated phenotype. Taken together, our findings confirm the involvement of this gene in neurodevelopmental disorders and are useful to strengthen the hypothesis that, although with variable expressivity and incomplete penetrance, the PARK2 microduplication is associated with a new emerging neurodevelopmental delay syndrome. However, clinical and molecular evaluations of more patients with the microduplication are needed for full delineation of this syndrome.",
keywords = "<italic>PARK2</italic>, Neurodevelopmental disorders, SNP array analysis",
author = "Orazio Palumbo and Pietro Palumbo and Leone, {Maria P.} and Raffaella Stallone and Teresa Palladino and Marcella Vendemiale and Stefano Palladino and Francesco Papadia and Massimo Carella and Rira Fischetto",
year = "2016",
month = "9",
day = "2",
doi = "10.1159/000448852",
language = "English",
journal = "Molecular Syndromology",
issn = "1661-8769",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - PARK2 Microduplication

T2 - Clinical and Molecular Characterization of a Further Case and Review of the Literature

AU - Palumbo, Orazio

AU - Palumbo, Pietro

AU - Leone, Maria P.

AU - Stallone, Raffaella

AU - Palladino, Teresa

AU - Vendemiale, Marcella

AU - Palladino, Stefano

AU - Papadia, Francesco

AU - Carella, Massimo

AU - Fischetto, Rira

PY - 2016/9/2

Y1 - 2016/9/2

N2 - We report on a patient with psychomotor deficits, language delay, dyspraxia, skeletal anomalies, and facial dysmorphisms (hirsutism, right palpebral ptosis, a bulbous nasal tip with enlarged and anteverted nares, and a mild prominent antihelix stem). Using high-resolution SNP array analysis, we identified a 0.49-Mb microduplication in chromosome 6q26 inherited from the mother involving the PARK2 gene: arr[hg19] 6q26(162,672,821-163,163,143)×3 mat. To the best of our knowledge, this is the third patient to date described in whom a 6q26 microduplication encompassing only the PARK2 gene has been reported in medical literature. The PARK2 gene is a neurodevelopmental gene that was initially discovered as one of the causes of autosomal recessive juvenile Parkinson disease and subsequently reported to be linked to autism spectrum disorders and attention-deficit hyperactivity disorders. We provide an overview of the literature on PARK2 microduplications and further delineate the associated phenotype. Taken together, our findings confirm the involvement of this gene in neurodevelopmental disorders and are useful to strengthen the hypothesis that, although with variable expressivity and incomplete penetrance, the PARK2 microduplication is associated with a new emerging neurodevelopmental delay syndrome. However, clinical and molecular evaluations of more patients with the microduplication are needed for full delineation of this syndrome.

AB - We report on a patient with psychomotor deficits, language delay, dyspraxia, skeletal anomalies, and facial dysmorphisms (hirsutism, right palpebral ptosis, a bulbous nasal tip with enlarged and anteverted nares, and a mild prominent antihelix stem). Using high-resolution SNP array analysis, we identified a 0.49-Mb microduplication in chromosome 6q26 inherited from the mother involving the PARK2 gene: arr[hg19] 6q26(162,672,821-163,163,143)×3 mat. To the best of our knowledge, this is the third patient to date described in whom a 6q26 microduplication encompassing only the PARK2 gene has been reported in medical literature. The PARK2 gene is a neurodevelopmental gene that was initially discovered as one of the causes of autosomal recessive juvenile Parkinson disease and subsequently reported to be linked to autism spectrum disorders and attention-deficit hyperactivity disorders. We provide an overview of the literature on PARK2 microduplications and further delineate the associated phenotype. Taken together, our findings confirm the involvement of this gene in neurodevelopmental disorders and are useful to strengthen the hypothesis that, although with variable expressivity and incomplete penetrance, the PARK2 microduplication is associated with a new emerging neurodevelopmental delay syndrome. However, clinical and molecular evaluations of more patients with the microduplication are needed for full delineation of this syndrome.

KW - <italic>PARK2</italic>

KW - Neurodevelopmental disorders

KW - SNP array analysis

UR - http://www.scopus.com/inward/record.url?scp=84986576018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986576018&partnerID=8YFLogxK

U2 - 10.1159/000448852

DO - 10.1159/000448852

M3 - Article

AN - SCOPUS:84986576018

JO - Molecular Syndromology

JF - Molecular Syndromology

SN - 1661-8769

ER -